(VIANEWS) – The NYSE opens in less than one hour and Teleflex‘s pre-market value is already 5% up.
Teleflex’s last close was $262.49, 26.42% below its 52-week high of $356.72.
The last session, NYSE ended with Teleflex (TFX) jumping 0.12% to $262.49. NYSE rose 0.07% to $15,379.13, following the last session’s upward trend on what was a somewhat bullish trend exchanging session.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Earnings Per Share
As for profitability, Teleflex has a trailing twelve months EPS of $7.68.
PE Ratio
Teleflex has a trailing twelve months price to earnings ratio of 44.55. Meaning, the purchaser of the share is investing $44.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.92%.
Volume
Today’s last reported volume for Teleflex is 312036 which is 8.05% below its average volume of 339370.
Sales Growth
Teleflex’s sales growth is negative 0.2% for the current quarter and 3.4% for the next.
More news about Teleflex (TFX).
